Eczema News and Research

Latest Eczema News and Research

Stopping necroptosis in keratinocytes prevents skin inflammation

The outer layer of the skin, called the epidermis, forms a critical physical and immunological wall that serves as the body's first line of defense against potentially harmful microorganisms. Most of the epidermis consists of cells called keratinocytes that build a mechanical barrier but also perform immune functions.

14 Oct 2011

Aquaporin AQP10 retains transport ability even when carbohydrate structure is removed

Water channels exist not only in nature - microscopical water channels are also present in the cells of the body, where they ensure that water can be transported through the protective surface of the cell. Scientists at the University of Gothenburg, Sweden, have discovered that one type of the body's water channels can be modified such that it becomes more stable, which may be significant in the treatment of several diseases.

11 Oct 2011

Children with asthma more likely to have been exposed to tobacco smoking before birth

Children with severe asthma are 3.6 times more likely to have been exposed to tobacco smoking before birth - even without later exposure - than children with a mild form of the disease, according to a multicenter study led by researchers at University of California, San Francisco.

23 Aug 2011

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

The corpus delicti is a plain flacon from among the possessions of Pharaoh Hatshepsut, who lived around 1450 B.C., which is on exhibit in the permanent collection of the Egyptian Museum of the University of Bonn. For three and a half millennia, the vessel may have held a deadly secret. This is what the Head of the collection, Michael H-veler-M-ller and Dr. Helmut Wiedenfeld from the university's Pharmacology Institute just discovered.

20 Aug 2011

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Amgen today announced that it will present data from several Prolia (denosumab) studies, including eight year efficacy and safety data from a Phase 2 extension study in women with postmenopausal osteoporosis with low bone mineral density (BMD), at the 2011 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in San Diego, Calif. from Sept. 16-20, 2011.

19 Aug 2011

Study: Vitamin D directly terminates production of MS-causing protein

While for years scientists have noted an association between levels of vitamin D in a person's body and the person's ability to resist or minimize the effects of multiple sclerosis (MS), the mechanism involved has not been established.

17 Aug 2011

Scientists identify potential target that could combat allergies of early childhood

A pandemic of ailments called the "allergic march" -- the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood -- has frustrated both parents and physicians. For the last three decades, an explosion of eczema, food allergies, hay fever, and asthma have afflicted children in the United States, the European Union, and many other countries.

16 Aug 2011

Impaired immunological memory causes psoriasis, atopic eczema

Scientists from the Centre for Allergy and Environment in Munich (ZAUM), the Helmholtz Zentrum München and the Technische Universität München have reached a milestone in their specialist area with their discovery of the causes of atopic eczema and psoriasis.

22 Jul 2011

FDA approves U.S. launch of Wiskott-Aldrich gene therapy clinical trial

The U.S. Food & Drug Administration (FDA) approved the launching in the U.S. of a clinical trial for gene therapy for a rare immunodeficiency, Wiskott-Aldrich syndrome.

22 Jul 2011

Partially hydrolysed whey formula does not prevent allergies in high-risk infants

Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.

15 Jul 2011

New corticosteroid with cream-like base

Upsher-Smith Laboratories, Inc. announced the launch of Trianex 0.05% (Triamcinolone Acetonide Ointment), a prescription topical corticosteroid offering the feel of a cream with the strength of an ointment.

11 Jul 2011

Levels of urinary eosinophil protein-X may predict future atopy in asymptomatic children

The signs of atopy may be present long before symptoms begin, even in month-old babies, according to a new research study from Denmark. The study found that the level of urinary eosinophil protein-X (u-EPX), a marker of inflammatory cells, in newborn babies was linked to higher risk of allergic sensitization, nasal eosinophilia and eczema at six years.

7 Jul 2011

Air traffic pollution impacts growth and development of unborn children

A UK academic is calling for a nationwide study into the effects traffic pollution has on asthma sufferers after his own research in Cairo highlighted health problems in children who may even be affected while still in the womb.

6 Jul 2011

Moberg Derma receives EU/EEA CE mark approval for Kaprolac Skin Repair & Hydration

Moberg Derma AB announced that CE mark has been granted for Kaprolac Skin Repair & Hydration, a product designed to treat atopic eczema and dry skin. This CE mark provides authorization to market and sell the product in the EU/EEA.

10 Jun 2011

Moisturisers, hair dyes cause serious adverse effects

Permanent hair dye gives the most serious adverse effects, yet there are also many reactions to facial and body moisturisers. This comes from the first report from the National Register of Adverse Effects from Cosmetic Products published by the Norwegian Institute of Public Health.

31 May 2011

Invida announces launch of novel atopic dermatitis symptomatic treatment

Invida Group Private Limited reaffirmed its commitment to patients in Asia Pacific by announcing the launch of a novel atopic dermatitis symptomatic treatment, Atopiclair, which will be available to patients across Asia in second half of 2011.

26 May 2011

Study: Healthy gut flora reduces risk of obesity and body's low-level inflammation

Poor gut flora is believed to trigger obesity. In the same way, healthy gut flora could reduce the risk. This has shown to be the case in tests on rats.

26 May 2011

Breastfeeding leads to better behaviour in kids: Study

A new study shows that just four months of breastfeeding can cut the risk of children becoming badly behaved by almost a third. It found 16 per cent of children brought up on formula milk had problems including anxiety, lying, stealing and hyperactivity – more than double the proportion breastfed for at least four months.

10 May 2011

New insight into itch and pain

A new study of itch adds to growing evidence that the chemical signals that make us want to scratch are the same signals that make us wince in pain.

3 May 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

Eczema News and Research

Latest Eczema News and Research

Stopping necroptosis in keratinocytes prevents skin inflammation

Aquaporin AQP10 retains transport ability even when carbohydrate structure is removed

Children with asthma more likely to have been exposed to tobacco smoking before birth

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Study: Vitamin D directly terminates production of MS-causing protein

Scientists identify potential target that could combat allergies of early childhood

Impaired immunological memory causes psoriasis, atopic eczema

FDA approves U.S. launch of Wiskott-Aldrich gene therapy clinical trial

Partially hydrolysed whey formula does not prevent allergies in high-risk infants

New corticosteroid with cream-like base

Levels of urinary eosinophil protein-X may predict future atopy in asymptomatic children

Air traffic pollution impacts growth and development of unborn children

Moberg Derma receives EU/EEA CE mark approval for Kaprolac Skin Repair & Hydration

Moisturisers, hair dyes cause serious adverse effects

Invida announces launch of novel atopic dermatitis symptomatic treatment

Study: Healthy gut flora reduces risk of obesity and body's low-level inflammation

Breastfeeding leads to better behaviour in kids: Study

New insight into itch and pain

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eczema News and Research

Latest Eczema News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in